Inside Strokecheck's mysterious rise and fall

A pharmacy-based stroke screening program has been shelved amid claims patients would have unnecessary ultrasounds and be scared by inaccurate results.

Strokecheck, a charity, courted controversy when it teamed up with pharmacy giant Amcal earlier this year, announcing a plan to set up temporary in-pharmacy clinics where GPs would assess people for stroke risk and order on-the-spot carotid artery ultrasounds if deemed necessary.

Now Amcal, which in late March was still defending its decision to partner with Strokecheck, has pulled the plug.

There is no doubt that Strokecheck had grand ambitions.